Medical device manufacture and point of care supply company to worldwide veterinary markets with an intent, through technology licensing, to expand into to the human clinical point of care arena.
First technology application: Urinary Tract Infection (UTI) technology which is at ‘allowed for issuance’ stage.
Technology: ATP Bioluminescence rapid Point of Care Detection & Management (Antibiotic Susceptibility) of UTI
2 -test system:
Test 1: detection of UTI in companion animal and human urine (5 mins)
Test 2: Antibiotic Susceptibility – to provide the investigating physician with data to be able to prescribe, with confidence, an antibiotic to treat the identified infection